Video

How to Gauge 10-Year Atherosclerotic CVD Risk for Patients

Patrick Curtin, PharmD, BCPS, Clinical Coordinator at Overlook Medical Center in Summit, New Jersey, addresses how to gauge 10-year atherosclerotic cardiovascular disease risk for patients relative to lifestyle, cholesterol, and obesity.

Patrick Curtin, PharmD, BCPS, Clinical Coordinator at Overlook Medical Center in Summit, New Jersey, addresses how to gauge 10-year atherosclerotic cardiovascular disease risk for patients relative to lifestyle, cholesterol, and obesity.

This video was recorded at Directions in Pharmacy's 5th annual CE conference in March 2015.

Related Videos
3d rendering of Bispecific antibodies or BsAbs have two distinct binding domains that can bind to two antigens or two epitopes of the same antigen simultaneously
Related Content
Cost-related non-adherence -- Image credit: jittawit.21 | stock.adobe.com
December 13th 2024

Approximately 1 in 6 US Adults With Asthma Report Non-Adherence to Medication Due to Cost

Gillian McGovern, Assistant Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

X-ray. ofheart -- Image credit: Anusorn | stock.adobe.com
December 13th 2024

FDA Expands Indication for Impella Heart Pumps to Include Pediatric Patients

Gillian McGovern, Assistant Editor
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
Tirzepatide, GLP-1, Semaglutide, Weight Loss | Image Credit: © zimmytws | stock.adobe.com
December 12th 2024

Tirzepatide Demonstrates Superiority for Weight Loss Compared With Semaglutide

Ashley Gallagher, Associate Editor
X-ray image of lungs with asthma -- Image credit: Sebastian Kaulitzki | stock.adobe.com
December 12th 2024

Benralizumab Achieves Positive Outcomes in Eosinophilic Exacerbations in Asthma, COPD

Gillian McGovern, Assistant Editor